PURIBLOOD MEDICAL CO., LTD.
Quem somos?
PURIBLOOD
PuriBlood Medical was founded by Dr. Yung Chang in 2016.
PuriBlood developed a unique technology for blood cell separation that is supported by a world-class research center – R&D center for membrane technology (RDCMT).
PuriBlood, in conjunction with RDCMT, holds over 36+ patents supporting our core membrane technology. PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)’.
Filtration Mechanism,
On the top layers of membrane structure, ZISC technol- ogy creates a membrane that is highly hydrated and compatible with human whole blood which is designed to evenly distribute the blood flow and trap the clots and microaggregates. (coarse-filtration)
In the core layers of membrane structure, ZISC technol- ogy provides a filter media with a specific affinity to selectively capture white blood cells and allows red blood cells to pass through the filter without rupture. (fine-filtration)
Os nossos valores
Our Company Vision:
Leadership
Leadership in product innovation.
Effectiveness
Extensive partnership /collaboration with clinicians to develop goods in demand.
Stability
Provide stable-quality cell filtration products to clients.
Flexibility
To satisfy clients’ requirements for various customized products of cell separation.